The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy
The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy
Not yet recruiting · NCT07475065 · Registry updated 2026-03-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Complications, Nutritional and Metabolic Diseases, central nervous system malformation, diabetes mellitus, diabetic neuropathy, diabetic polyneuropathy, endocrine system disorder, glucose metabolism disease, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy | Not yet recruiting | Phase 2 / Phase 3 | 2026-03-16 | NCT07475065 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dexa Medica Group | 4 |
| Universitas Sebelas Maret | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dr. Moewardi Regional General Hospital | Surakarta | Indonesia | 1 |